Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02091037 · ClinicalTrials.gov registry record
S. Aureus Colonization in Atopic Dermatitis
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 114
- Enrollment target
NCT02091037: Completed study, sponsored by Columbia University.
NCT02091037 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 114 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02091037 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the bacterial strains that colonize children with atopic dermatitis. The investigators hypothesize that rectal cultures will be more sensitive than anterior nares cultures for detecting S. aureus colonization, and that strains of S. aureus colonizing patients with atopic dermatitis will be resistant to commonly used topical antibiotic ointments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2011-12 |
| Est. Completion | 2017-01-11 |
What the finished NCT02091037 record still lists
NCT02091037 is an observational study that tracks outcomes without assigning an intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02091037 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02091037 about?
NCT02091037 is a clinical study titled "S. Aureus Colonization in Atopic Dermatitis". The purpose of this study is to characterize the bacterial strains that colonize children with atopic dermatitis. The investigators hypothesize that rectal cultures will be more sensitive than anterior nares cultures for detecting S. aureus colonization, and that strains of S. aureus colonizing pat...
What is the current status of trial NCT02091037?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2011-12. Estimated completion is 2017-01-11.
Who is sponsoring clinical trial NCT02091037?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia